Executive Team

 
 
Mark-Hinds-Headshot-SS-BW.jpg

Mark Hinds : : CEO

  • Successful Serial Entrepreneur

  • 1998-2006: Turned $16.8M into $121M (IPO) w/ real estate

  • Co-Developer of The Resonance Project (w/ Nassim Haramein)

  • 2011 Novus Via Co-Founder, Successfully Raised $20M

  • Funding scientists, researchers, doctors and others  for 17 years

Roland-Vandermeer-headshot-SS-BW.jpg

Roland Vandermeer : : PRESIDENT  

  • 20 years of venture early stage investing, 10 years of real asset investor

  • Managed over $1.5B capital

  • Over 20% IRR personal track record  

  • Ultra Capital, Managing Director; Equilibrium Capital, Principal; Biological Capital, Chairman; ComVentures, Managing Director, Hambrecht & Quist, Associate   

  • M&T Dual degree, Wharton and U. Penn Engineering

Alicia-Fantozzi-SS.png

ALICIA FANTOZZI:  CFO

Ms. Alicia Fantozzi spent the past 20 years in emerging market investment banking and tax structured finance based in London with a primary focus in structured credit derivatives, project and structured finance, multi-jurisdictional tax structuring, distressed assets, commodities, debt and equity origination, Private equity, IPOs, M&A, and Private Placements.

Ms. Fantozzi has been engaged as Principal in tax structured finance for a private multiple family office boutique, Managing Director Royal Bank of Scotland in credit derivatives & structured finance, London; Executive Director in Structured Credit at JP Morgan, London, and investment banking VP & Analyst at Morgan Stanley, London.

Ms. Fantozzi has a concentration in developing market risk assessment, business intelligence, crisis management, and security operations including cross border fraud investigations.

Ms. Fantozzi has been involved in Institutional capital raising of over $10Bn, and distressed asset portfolio workouts & restructurings of over $4Bn. Alicia holds a B.S. from U.C. Berkeley in Geopolitics, studied concert piano and music composition at  the Vienna Conservatory of Music, and is proficient in 5 languages.

Victoria-Hale-Headshot-SS-BW.jpg

VICTORIA HALE PHD : : DIRECTOR of HEALTH

  • Pharmaceutical scientist

  • CEO of two non profit pharmaceutical companies

  • Numerous FDA approvals

  • University and global partnership expert.

  • Has raised over $230M in funding.

  • Dr. Hale has been honored with MacArthur Fellowship, many other accolades and achievements.

  • Worked with FDA, Genentech, Meds360 and more

Michael-Sutton-headshot-BW-SS.jpg

MICHAEL SUTTON : : Director OF OPERATIONS

  • Extensive operating and marketing experience across multiple industries.

  • Founder and CEO of Luminas - the first frequency imprinting health products company

  • COO of one of the largest private apparel companies in US, overseeing operations that delivered billions of dollars of product.

Robert-Finley-SS-BW.jpg

ROBERT FINLEY : : DIRECTOR ENERGY SECTOR

  • 30 years of experience in business development, operations management, product design in the technology and energy sectors.

  • President and CEO of a semiconductor startup.

  • Electrical Engineer who can bridge the two worlds of over-unity technology and standard physics.

  • 12 years experience in business development of energy technologies.

Beth-McDougall-MD-headshot-BW-SS.jpg

BETH MCDOUGALL, MD : : CHIEF MEDICAL OFFICER

  • 20+ years as a specialist in immunological & neurodegenerative health conditions.

  • Currently leading research in advanced stem cell therapies and regenerative medicine.

  • Allopathic Internal medicine doctor with functional orthomolecular & European biological medicine expertise.

Nassim-Headshot-SS-BW.jpg

Nassim Haramein : : Advisor CTO

  • Scientist and discoverer, Resonance Physics, a new physics paradigm

  • Featured presenter and lecturer

  • Executive Director, Research & Development, Resonance Science Foundation